RxDoctor Payments Data

Lindsey Santillo, PA

Physician Assistant · Elgin, ILNPI 1841811684

Payments from drug & device makers

$559in general payments, 2019–2025

Across 21 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$119
  • Novo Nordisk$114
  • Alkermes, Inc.$76
  • Bayer$54
  • Johnson & Johnson$39
  • Exact Sciences$35
  • plus $122 from 5 others

What the payments were for

  • Food & beverage$559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$559 in reported general payments places this provider in the 65th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$135,803
Medicare patients
317
Services billed
4,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin66$105,338
OzempicSemaglutide23$46,803
MounjaroTirzepatide33$39,062
TrulicityDulaglutide17$36,482
JanuviaSitagliptin Phosphate32$33,752
EliquisApixaban14$17,156
MyrbetriqMirabegron11$5,880
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$4,350
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$4,019
Atorvastatin Calcium279$2,082
Levothyroxine Sodium149$1,398
Tamsulosin Hcl67$1,315
Amlodipine Besylate137$1,291
Metoprolol Succinate60$1,148
Albuterol Sulfate HfaAlbuterol Sulfate43$1,100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$114$46,80323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Elgin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →